European Patent Office

T 0394/20 (Bluetongue virus vaccine/ZOETIS) of 22.03.2022

European Case Law Identifier
ECLI:EP:BA:2022:T039420.20220322
Date of decision
22 March 2022
Case number
T 0394/20
Petition for review of
-
Application number
08853123.1
IPC class
A61K 39/15
Language of proceedings
English
Distribution
No distribution (D)
OJ versions
No OJ links found
Other decisions for this case
-
Abstracts for this decision
-
Application title
Bluetongue virus vaccine and immunogenic compositions, methods of use and methods of producing same
Applicant name
Zoetis Belgium S.A.
Opponent name
Boehringer Ingelheim Animal Health USA Inc.
Board
3.3.04
Headnote
-
Relevant legal provisions
European Patent Convention Art 100(a)European Patent Convention Art 111(1)European Patent Convention Art 56Rules of procedure of the Boards of Appeal Art 13(2)
Keywords
Inventive step - obvious alternative
Amendment after summons - exceptional circumstances (no)
Amendment after summons - taken into account (no)
Amendment after summons - cogent reasons (no)
Remittal to the department of first instance (no)
Catchword
-
Cited cases
T 0197/86
Citing cases
-

Order

For these reasons it is decided that:

1. The decision under appeal is set aside.

2. The patent is revoked.